DHR: Raised 2026 guidance after strong Q2 results, robust orders, and successful Masimo acquisitionQuartr·Jul 21 at 09:07 AMMASI0.00%DHR-0.19%
Transcript: Danaher Q2 2026 Earnings Conference Callbenzinga_article·Jul 21 at 08:36 AMDHR-0.19%MASI0.00%
Danaher Q2 FY26 net earnings rise 60% to $870 million; revenue increases 5.5% to $6.3 billionPUBT·Jul 21 at 05:02 AMDHR-0.19%
Danaher sees earnings lift from Masimo deal and bioprocessing reboundCoinLive·Jul 16 at 01:11 PMDHR-0.19%MASI0.00%
Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk SoonerUnusual Whales·Jun 22 at 07:11 AMMASI0.00%
Masimo wins FDA clearance for AI opioid respiratory depression detection on Radius VSM monitorPUBT·Jun 22 at 07:01 AMMASI0.00%
Fieldview Capital Management LLC Has $1.65 Million Stock Holdings in Danaher Corporation $DHRMarket Beat·Jun 15 at 03:33 AMDHR-0.19%MASI0.00%
Akre Capital Management LLC Decreases Stake in Danaher Corporation $DHRMarket Beat·Jun 14 at 02:19 AMDHR-0.19%
Brown Advisory Inc. Has $798.30 Million Holdings in Danaher Corporation $DHRMarket Beat·Jun 14 at 02:54 AMDHR-0.19%MASI0.00%
Danaher Completes Acquisition of Masimo Corporation | DHR Stock NewsStockTitan·Jun 9 at 11:55 PMMASI0.00%DHR-0.19%
